Cardiovascular Systems IncCardiovascular Systems Inc - ESG Rating & Company Profile powered by AI

Industry Group:Medical Equipment, Supplies & Distribution

This webpage displays a free E,S&G report for Cardiovascular Systems Inc. This Sustainability score for Cardiovascular Systems Inc represents the company's reporting of the United Nations Sustainable Development Goals. This report of Cardiovascular Systems Inc leverages data from across the internet and also from public filings by Cardiovascular Systems Inc.

Cardiovascular Systems Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 5.3, social score of 5.7 and governance score of 7.0.

SDG Transparency Score for Cardiovascular Systems Inc 
Low
0 - 3

6.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Cardiovascular Systems Inc 
5.3

Environmental

5.7

Social

7.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Becton Dickinson and Co
8.6
High
2DENTSPLY SIRONA Inc
8.4
High
111Sientra Inc
6.3
High
111Yamashita Health Care Holdings Inc
6.3
High
120Cardiovascular Systems Inc
6.2
High
120Avedro Inc
6.2
High
120Steris plc
6.2
High
.........
526Valeritas Holdings Inc
0.0
Low
526ZoomMed Inc
0.0
Low
.........
View the full peer group of 681 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Cardiovascular Systems Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc offer flexible work?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Cardiovascular Systems Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose water use targets?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Cardiovascular Systems Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Cardiovascular Systems Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Cardiovascular Systems Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose its waste policy?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose energy use targets?

LockedSign up for free to unlock

Does Cardiovascular Systems Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Cardiovascular Systems Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Cardiovascular Systems Inc
These potential risks are based on the size, segment and geographies of the company.

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Sorry!

Failed to process!